These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12761341)

  • 1. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Jun; 63(6):1312-21. PubMed ID: 12761341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site of action of beta-ligands at the human beta1-adrenoceptor.
    Baker JG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1163-71. PubMed ID: 15716385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptor.
    Baker JG; Proudman RG; Hawley NC; Fischer PM; Hill SJ
    Mol Pharmacol; 2008 Nov; 74(5):1246-60. PubMed ID: 18687809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.
    Baker JG; Proudman RG; Tate CG
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.
    Baker JG; Hall IP; Hill SJ
    Br J Pharmacol; 2002 Oct; 137(3):400-8. PubMed ID: 12237261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.
    Gherbi K; Briddon SJ; Hill SJ
    Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    PLoS One; 2013; 8(11):e77582. PubMed ID: 24250787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.
    Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ
    FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta1-adrenoceptors in rat anterior pituitary may be constitutively active. Inverse agonism of CGP 20712A on basal 3',5'-cyclic adenosine 5'-monophosphate levels.
    Janssens K; Boussemaere M; Wagner S; Kopka K; Denef C
    Endocrinology; 2008 May; 149(5):2391-402. PubMed ID: 18202135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers.
    Joseph SS; Lynham JA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):525-32. PubMed ID: 15060759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
    Sarsero D; Molenaar P; Kaumann AJ
    Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
    Konkar AA; Zhai Y; Granneman JG
    Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors.
    Konkar AA; Zhu Z; Granneman JG
    J Pharmacol Exp Ther; 2000 Sep; 294(3):923-32. PubMed ID: 10945842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor.
    Chakir K; Xiang Y; Yang D; Zhang SJ; Cheng H; Kobilka BK; Xiao RP
    Mol Pharmacol; 2003 Nov; 64(5):1048-58. PubMed ID: 14573753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
    Nisoli E; Tonello C; Landi M; Carruba MO
    Mol Pharmacol; 1996 Jan; 49(1):7-14. PubMed ID: 8569714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Dec; 64(6):1357-69. PubMed ID: 14645666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.